GENE ONLINE|News &
Opinion
Blog

EGFR
SystImmune Partners with Bristol-Myers Squibb to Develop and Commercialize Bispecific ADC Globally
2023-12-13
FDA Approves First Targeted Therapy for EGFR Lung Cancer with Exon 20 Mutations
2021-05-24
R&D
ASCO 2020: Keytruda Chemo Combo Show Significant Benefit in PD-L1 Expressing mTNBC
2020-06-03
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Overwhelming Efficacy Allows AstraZeneca to End Cancer Drug Trial Sooner
2020-04-12
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Single-cell genomic analysis (SCG)—A Key to Decipher the Cancer Landscape
2020-01-04
Weekly in Asia | SEP-1
2019-09-17
Kisqali Fulvestrant Combo Rejected by NICE for Breast Cancer Treatment in the UK
2019-05-02
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Fighting Lung Cancer with Precision Warfare
2018-06-21
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top